Clinical manifestations of tropical pulmonary eosinophilia syndrome include cough, shortness of breath, and wheezing. The eosinophilia is often accompanied by high levels of Immunoglobulin E IgE and antifilarial antibodies. The standard method for diagnosing active infection is the examination of blood under the microscope to identify the microscopic worms, called microfilariae.
This is not always feasible because in most parts of the world, microfilariae are nocturnally periodic, which means that they only circulate in the blood at night. For this reason, the blood collection has to be done at night to coincide with the appearance of the microfilariae in the blood. Serologic techniques provide an alternative to microscopic detection of microfilariae for the diagnosis of lymphatic filariasis.
Because lymphedema may develop many years after infection, lab tests are often negative with these patients. Avoiding mosquito bites is the best form of prevention. The mosquitoes that carry the microscopic worms usually bite between the hours of dusk and dawn. If you live in or travel to an area with lymphatic filariasis:. People infected with adult worms can take a yearly dose of medicine, called diethylcarbamazine DEC , that kills the microscopic worms circulating in the blood.
While this drug does not kill all of the adult worms, it does prevent infected people from giving the disease to someone else. People with lymphedema and elephantiasis are not likely to benefit from DEC treatment because most people with lymphedema are not actively infected with the filarial parasite.
People with lymphedema and hydrocele can benefit from lymphedema management, and in the case of hydrocele surgical repair. Even after the adult worms die, lymphedema can develop. You can ask your physician for a referral to see a lymphedema therapist for specialized care.
Prevent the lymphedema from getting worse by following several basic principles:. Contact Us. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Parasites - Lymphatic Filariasis. Section Navigation. There are a number of Aedes , Anopheles , and Culex species present in Australia, and a single species of Mansonia. The vector status of many of these species is unknown, but many bite humans only rarely and are therefore unlikely to be vectors; other species primarily inhabit swamps and bushland, which would reduce their effectiveness in transmitting LF or other vector-borne diseases.
Historically, this mosquito, which has a very broad range and is present worldwide, was the main transmitter of LF, although it may have been quite inefficient in this regard, which may have contributed to the eventual elimination of LF in Australia [ 7 , 8 ].
Its breeding habitats include ditches, drains, and septic tanks and it is common in urban areas with poor drainage and sanitation [ ]. Other species capable of transmitting LF present in Australia are: An. Aedes albopictus , an invasive mosquito species not native to Australia, has previously been introduced into the islands of the Torres Strait [ ] and mainland Australia [ ], and has also become established in Asia, Europe, Africa, and the Americas.
Aedes albopictus is an important mosquito species due to its successful establishment in many parts of the world and its ability to act as a vector of both LF and dengue.
This mosquito is no longer present in Australia due to successful control programs. However, it is still present in PNG and Indonesia, and thus colonisation could potentially occur in the future if mosquito control programs are halted. Transmission of LF is quite inefficient, with upwards of several hundred to thousands of infective bites required for transmission to occur [ ].
Different mosquito species also have varying efficiencies and in general, there is lower vector efficiency observed in the Pacific and Oceania than observed in Africa [ ]. In early studies in Tanzania and Liberia, where the vectors were C. The lowest number of bites was , also in Tanzania. The lowest number was in Malaysia, where the infective species was B.
A factor that could greatly influence this is that the mf are not injected into the blood as is the case in malaria, but are introduced onto the skin, with the mf then making their way into the bite wound and thus into the blood [ 14 ].
The skin is a generally harsh environment for micro-organisms to survive in; it can be quite dry, and secretes substances which can cause the skin to become more acidic and also damage or cause death. Therefore, transmission is less straight forward than occurs with vector-borne pathogens that are injected directly into the blood.
Some mosquito species are more efficient at transmitting LF than others. Vector competency relies on the uptake of mf from the infected human host, development in the mosquito to the infective L3 larvae, and transmitting those infective larvae to humans [ , , , , ]. Certain species of mosquito are able to transmit parasites from humans harbouring low levels of mf, whereas other species can only transmit when high numbers of mf are present; paradoxically, very high levels of mf have been associated with the early death of mosquitoes [ , ].
The mf can also demonstrate nocturnality [ ]; thus, mosquitoes taking a blood meal during the day are likely to encounter low parasitaemia which, depending on the mosquito species and when they are active, may limit transmission. There is a strain of W. Additionally, the time of day that the infected mosquito is feeding will affect when mf can be seen in the blood, with peak mf levels in the blood observed during the peak biting periods of the mosquitoes [ ].
While some mosquitoes are classified as day biters, there is often peak biting in the early morning and evening, such as the case with Ae. Polynesiensis is considered a good vector of LF [ , ], likely due to a number of factors, including its high biting frequency, compared with other mosquitoes [ ]. A high biting frequency will decrease the time required for infection to occur. Anopheles spp.
Mosquitoes, resulting in less damage to mf [ , , ]. However, results on mf uptake and damage vary between species, geographical location, and study design. A study on the vector competency of Anopheles species in PNG showed a considerable difference in ingested mf between An. The mf recovered from mosquitos were examined for damage during uptake, although An. As a proportion, more mf were damaged in low-intensity infections.
The filarial vector competency of Ae. As indicated in older studies, it appears that C. However, it is possible that there are geographic differences between the mosquito species which may cause variation in LF-transmitting ability. One study compared Ae. Based on climate modelling — , the eastern seaboard of Australia would provide suitable habitats for Ae. In Europe, climate change has already impacted the transmission of vector-borne diseases by expanding tropical and subtropical zones and this has led to increases in the survivability zones for insect vectors, particularly mosquitoes.
This has resulted in the spread of Dirofilaria species, zoonotic filarial nematodes which utilise mosquitoes as transmission vectors, into new areas in Europe [ 6 ]. Other species capable of transmitting LF are already present in Australia, such as C. The introduction from outside Australia of Ae. This mosquito is exclusively tropical, and climate change may increase its viable range in Australia.
It is therefore important to prevent its spread, particularly as it can also act as a vector for dengue, chikungunya, and Ross River viruses [ , , ]. LF appears not to have been endemic on mainland Australia prior to European colonisation, but was present in the islands of the Torres Strait, and was thought to be introduced several times by immigrants from China and the Pacific Islands.
Relevant mosquito species that can transmit LF are present in all states of Australia. Immigration will continue to be a concern for the importation of new diseases including mosquito-transmitted infections such as dengue and chikungunya, as well as LF. Current control measures in North Queensland against Ae.
LF is a very poorly-transmitted disease, requiring the presence of a highly concentrated population of infected individuals for successful spread.
The absence of a competent mosquito host such as Ae. It is therefore very unlikely that LF will ever become re-established in Australia, with only sporadic reports of infections in returned travelers and, more likely, in immigrants and refugees from endemic areas. The main area of risk to Australia for the re-introduction of LF remains the Torres Strait islands, which lie very close to endemic PNG in the north and mainland Australia in the south.
The potential for the re-introduction of LF onto the Australian mainland seems remote. As LF caused by W. Monitoring in the Torres Strait, however, should occur as the risk of infection introduced from PNG remains a threat, albeit at a low level.
All authors have read and approved the final paper. National Center for Biotechnology Information , U. Trop Med Infect Dis. Published online Jun 4. Catherine A. Jones , 2 and Donald P. McManus 1. Malcolm K. Donald P. Author information Article notes Copyright and License information Disclaimer. Received Apr 26; Accepted May This article has been cited by other articles in PMC. Abstract Lymphatic filariasis LF infects an estimated million people worldwide, with a further million considered at risk of infection and requiring preventative chemotherapy.
Keywords: Wuchereria bancrofti , lymphatic filariasis, elephantiasis. Introduction Lymphatic filariasis LF , also known as Bancroftian filariasis or elephantiasis—due to swelling often in the lower limbs and genitals, upper limbs, and other areas of the body—is part of Australian history, with father and son, Dr. Open in a separate window. Figure 1. Figure 2.
Lifecycle Although explored more fully below, the life-cycle is presented here. Figure 3. Disease The pathology which manifests in the human host is varied, and a small proportion of long-term chronic cases can develop to the state that is referred to as elephantiasis, in reference to the swelling and thickening of the skin that can occur as a result of infection.
Diagnosis The two most common forms of diagnostic procedures for W. Blood Smears mf Detection Blood smears detect mf in the blood of an infected patient. Other Diagnostic Methods While the ICT and blood smears are the most common procedures used, there are a number of other available diagnostic tests including molecular- and serological-based assays.
Prevention and Treatment One of the best methods of thwarting the spread of a vector-borne disease involves targeting the vector, so as to prevent the mosquito from biting but also as a general mosquito population control measure.
History of LF in Australia The work of unravelling the lifecycle of LF relied on observations of a number of physicians and parasitologists over many years Figure 1. Discovering the Vector Bancroft wondered how such parasites living in the blood might be transmitted and hypothesised the involvement of a mosquito vector, a hypothesis also put forward by Manson [ 50 ]. Active Transmission 8.
Active Surveillance 8. Micronesia Micronesia is a collection of thousands of islands to the north of Australia Figure 2. Fiji Fiji lies to the east of Australia and comprises more than islands Figure 2. Elimination Achieved 8. Solomon Islands The Solomon Islands lie to the north-east of Australia Figure 2 and have a history of LF, although the disease is considered eliminated today—possibly as an added benefit of mosquito control for malaria eradication.
Republic of Vanuatu Vanuatu is an Island group comprising around 80 islands that lie to the north of New Caledonia and km east of Australia Figure 2. Tonga Tonga lies to the east of Australia and is made up of islands in the Pacific Ocean Figure 2. Niue Niue current population is a small self-governing state in association with New Zealand to the east of Tonga and south of American Samoa Figure 2.
Mosquito Hosts for LF Climate and Potential Spread of Mosquito Vectors in Australia Based on climate modelling — , the eastern seaboard of Australia would provide suitable habitats for Ae. Conclusions LF appears not to have been endemic on mainland Australia prior to European colonisation, but was present in the islands of the Torres Strait, and was thought to be introduced several times by immigrants from China and the Pacific Islands. Author Contributions C.
Conflicts of Interest The authors declare no conflict of interest. References 1. Angus B. Volume 53 Queensland Museum; Queensland, Austrialia: Goel T. Lymphatic Filariasis. Springer Nature; Singapore: Hajdu S. Small S. Population genetics of the filarial worm Wuchereria bancrofti in a post-treatment region of Papua New Guinea: Insights into diversity and life history.
PLoS Negl. WHO Lymphatic Filariasis. Gordon C. The increase of exotic zoonotic helminth infections: The impact of urbanization, climate change and globalization.
Boreham P. Human filariasis in Australia: Introduction, investigation and elimination. Sasa M. Human Filariasis. Univeristy of Tokyo Press; Tokyo, Japan: Jeremiah C. Lymphatic filariasis in Australia: An update on presentation, diagnosis and treatment. Kline K. Neglected tropical diseases of Oceania: Review of their prevalence, distribution, and opportunities for control. Graves P. Lymphatic filariasis in Papua New Guinea: Distribution at district level and impact of mass drug administration, to WHO Summary of global update on preventive chemotherapy implementation in Crossing the billion.
Joseph H. Laboratory diagnosis of lymphatic filariasis in Australia: Available tools and interpretation. Shenoy R. Lymphatic filariasis in children: Clinical features, infection burdens and future prospects for elimination. Lammie P. The pathogenesis of filarial lymphedema: Is it the worm or is it the host? Clinical and pathological aspects of filarial lymphedema and its management. Korean J. Melrose W. Lymphatic filariasis: New insights into an old disease.
Stocks M. The effect of hygiene-based lymphedema management in lymphatic filariasis-endemic areas: A systematic review and meta-analysis. Mullerpattan J. Tropical pulmonary eosinophilia—A review. Indian J. Southeast Asian J. Public Health. Knott J. The periodicity of the microfilaria of Wuchereria bancrofti. Preliminary report of some injection experiments.
Jongthawin J. Detection and quantification of Wuchereria bancrofti and Brugia malayi DNA in blood samples and mosquitoes using duplex droplet digital polymerase chain reaction. Weerakoon K. Cell-free DNA as a diagnostic tool for human parasitic infections. Trends Parasitol. Weil G. The ICT filariasis test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Identification and partial characterisation of a parasite antigen in sera from humans infected with Wuchereria bancrofti.
Wanji S. Cross-Reactivity of filariasis ICT Cards in areas of contrasting endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for shrinking of the lymphatic filariasis map in the central African region. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood.
WHO; Geneva, Switzerland: Masson J. Relative performance and predictive values of plasma and dried blood spots with filter paper sampling techniques and dilutions of the lymphatic filariasis Og4C3 antigen ELISA for samples from Myanmar. El-Moamly A. Reeve D. Evaluation of the Og34C filter paper technique in lymphatic filariasis prevalence studies.
Supali T. Estimation of the prevalence of lymphatic filariasis by a pool screen PCR assay using blood spots collected on filter paper. Debrah A. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Turba M. Detection of Wolbachia DNA in blood for diagnosing filaria-associated syndromes in cats.
Bockarie M. Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea. Reimer L. Insecticidal bed nets and filariasis transmission in Papua New Guinea. Anderson N. Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis. Vaccine Immunol. Ichimori K. MDA-lymphatic filariasis.
Macrofilaricidal activity in Wuchereria bancrofti after 2 weeks treatment with a combination of rifampicin plus doxycycline. Noroes J. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Vanamail P. Estimation of the fecund life span of Wuchereria bancrofti in an endemic area. Lim K. Surgical treatment of genital manifestations of lymphatic filariasis: A systematic review. World J. Foster W. A History of Parasitology.
Livingstone LTD. Peard J. Cobbold T. On the discovery of the intermediate host of Filaria sanguinis hominis. Bancroft P. Discussion of a paper by E. Bancroft J. Diseases of animals and plants that interfere with colonial progress. Hall Rec. Sweet W. Final Report Australian Hookworm Campaign. Australian Hookworm Campaign; Brisbane, Australia: Report on malaria and filaria survey of Australia and on mosquito surveys in Queensland, Western Australia and Northern Territory; pp.
Part II. Mackerras I. The Bancrofts: A century of scientific endeavour. Discovery of the adult representative of microscopic filariae. On filaria bancrofti. Verification of recent haematozoal discoveries in Australia and Egypt. Bourne A. A note on Filaria sanguinis hominis : With a description of a male specimen.
Trewin B. The elimination of the dengue vector, Aedes aegypti , from Brisbane, Australia: The role of surveillance, larval habitat removal and policy.
Bancroft T. Notes on filaria in Queensland. Filarial metamorphosis in the mosquito. Metamorphosis of Filaria bancrofti Cobbold. It is a major cause of disability in endemic areas. When someone is bitten by an infected mosquito, microscopic larvae are left on the skin and can enter the person's body. The larvae can then migrate to the lymph system , where they develop into mature roundworms and can live for years.
People are usually infected with lymphatic filariasis in childhood but don't develop symptoms until later in life. About million people in the world are affected with elephantiasis, mainly in Asia, Africa, the Western Pacific and parts of the Caribbean and South America. It usually takes repeated mosquito bites over several months or years in an area where lymphatic filariasis is common for a person to become infected. It is very rare to be infected after only visiting the area for a short time.
Elephantiasis can make you more likely to get infections. If you have elephantiasis, see your doctor straight away if you develop any swelling, thickening of the skin or signs of an infection. Elephantiasis is diagnosed with a blood test , which looks for the microscopic worms.
The blood must be taken at night, when the worms are most active. However, the swelling may not happen until many years after the person is infected, so the lab tests are often negative. X-rays and ultrasounds might also be used to rule out other causes of the swelling. Elephantiasis is treated with medicine to kill the microscopic worms. The medicine stops the infection from being passed on to other people, but it may not kill all the worms. An infected person will usually need to take the medicine for several weeks.
Antibiotics , pain killers and antihistamines may also be prescribed to control the symptoms. Elephantiasis can be very upsetting, disabling and can stop you leading a normal life.
It can contribute to stigma and poverty, but counselling and support groups may help. Talk to your doctor about this.
0コメント